Clearly, a group of responder AML cell lines was characterized by significantly higher levels of STAT5 S726 (Figure 7E) and STAT1 S727 (Figure 7F), whereas cell lines resistant to CDK8 inhibitors were largely negative for these phosphorylation marks. The gene discussed is CDK8; the disease is acute myeloid leukemia.